{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":1320,"summary":"Hosted by Corey with the Story. Stay informed with the latest business, stock market, and finance headlines, updates, and breaking stories delivered daily in quick, engaging episodes. Subscribe! The Daily News Now! — Every city. Every story. AI-powered. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-06-17T18:18:57.837082+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"J&J Aims to Cure or Control Cancer in 10 Years","slug":"j-j-aims-to-cure-or-control-cancer-in-10-years","published_at":"2026-06-16T17:09:25+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/j-j-aims-to-cure-or-control-cancer-in-10-years","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/044f3709-5e00-41ac-b20d-678d5c87afaa.mp3","audio_url":"https://api.fastcast.ai/audio/044f3709-5e00-41ac-b20d-678d5c87afaa.mp3","summary":"J&J’s CEO Joaquin Duato unveiled a bold 10-year plan to either cure or manage certain cancers like chronic diseases, aiming for oncology dominance by 2030. Fueling this mission, J&J is leveraging AI to turbocharge drug development and just acquired Firefly Bio for $1 billion to gain its revolutionary Firelink platform—targeting deadly KRAS-mutated tumors with precision therapy that could slash patient suffering and expand their pipeline dramatically. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/2525b7794165c8b9","meta_description":"J&J’s CEO Joaquin Duato unveiled a bold 10-year plan to either cure or manage certain cancers like chronic diseases, aiming for oncology dominance by…","key_points":[],"chapters":[],"topics":[],"duration_seconds":113,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/j-j-aims-to-cure-or-control-cancer-in-10-years/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/j-j-aims-to-cure-or-control-cancer-in-10-years.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}